BackAeglea BioTherapeutics Overview
Aeglea BioTherapeutics Inc

Aeglea BioTherapeutics Discounted Cash Flow

DCF Analysis for AGLE.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$12.29

Current Fair Value

$12.29
2.4% Upside

Undervalued by 2.4% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading